quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:26·994d
SECFiling
Codex DNA Inc. logo

SEC Form EFFECT filed by Codex DNA Inc.

DNAY· Codex DNA Inc.
Health Care
Original source

Companies

  • DNAY
    Codex DNA Inc.
    Health Care

Recent analyst ratings

  • Mar 2UpdateCowen-
  • Oct 15UpdateCowen-
  • Jul 13UpdateJefferies$23.00
  • Jul 13UpdateCowen & Co.-
  • Jul 13UpdateKeybanc$30.00

Related

  • INSIDER870d
    SEC Form 4 filed by Kullback William J
  • INSIDER870d
    SEC Form 3 filed by new insider Kullback William J
  • SEC875d
    Codex DNA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
  • SEC892d
    SEC Form 10-Q filed by Codex DNA Inc.
  • SEC892d
    Codex DNA Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
  • SEC896d
    Codex DNA Inc. filed SEC Form 8-K: Events That Accelerate or Increase a Direct Financial Obligation
  • INSIDER911d
    Herrema Gregory J. was granted 153,191 shares (SEC Form 4)
  • INSIDER911d
    SEC Form 3 filed by new insider Herrema Gregory J.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022